The European Pharmaceutical Wholesale Industry: - phagro
The European Pharmaceutical Wholesale Industry: - phagro
The European Pharmaceutical Wholesale Industry: - phagro
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
41<br />
<strong>The</strong> <strong>European</strong> <strong>Pharmaceutical</strong> <strong>Wholesale</strong> <strong>Industry</strong><br />
On average, medicines are ordered from manufacturers from 2.5 times a month in<br />
the UK up to 4.5 times in the NL. In case of special need order-frequencies for<br />
certain products are, of course, higher. In some northern <strong>European</strong> countries, order<br />
frequencies of some companies exceed the average up to 3 times.<br />
<strong>The</strong> relationship between the pharmaceutical industry and wholesalers is affected<br />
by the provision of services by the latter creating added value for manufacturers.<br />
<strong>The</strong> most important of these services are related to marketing activities and promotional<br />
support, the provision of sales and inventory statistics but also assistance<br />
at product launches or offering logistics services of clinical trials. As these<br />
services form an integrative part in the relationship with manufacturers, it is<br />
widely expected within the industry that the importance of such services is likely<br />
to rise considerably in the near future as competition between wholesalers, but<br />
also between pharmaceutical companies, is speeding up. In times of increasing<br />
direct distribution and a strained relationship between manufacturers and wholesalers<br />
in the debate on supply quota systems, services more and more become<br />
the crucial competitive factor in pharmaceutical wholesaling.<br />
6.3.2 Warehousing<br />
Items on stock ranged from 6,000 to more than 90,000 depending on the size of<br />
the market and the number of pharmaceuticals 12 authorized to be marketed. On a<br />
<strong>European</strong> average, wholesaler stock 29,151 different items, of which 49% are<br />
pharmaceuticals. <strong>The</strong> share of medicines within the product range differs considerably<br />
from country to country, depending on the number of pharmaceuticals allowed<br />
for marketing.<br />
Figure 34: <strong>Pharmaceutical</strong>s and non-<strong>Pharmaceutical</strong> Products on Stock<br />
(in thousand), 2004<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
90<br />
54<br />
76<br />
25<br />
50<br />
33<br />
33<br />
GER IT AUT NL FR UK ESP<br />
IPF Institute for Pharmaeconomic Research<br />
21<br />
28<br />
14<br />
Products on stock <strong>Pharmaceutical</strong>s on stock<br />
Source: IPF research<br />
12<br />
<strong>The</strong> term pharmaceuticals denotes all Rx and OTC products. Para-pharmaceuticals are<br />
classified as non-pharmaceuticals.<br />
18<br />
12<br />
28<br />
10